关于探索泰特兰地林的治疗潜力和结构修饰的见解
Liang Gong1,2, He Liu1, Bo Xu1
1Department of Medicinal Chemistry, Third Military Medical University, Chongqing, China.
Future medicinal chemistry
|November 28, 2024
概括
目前正在开发四氨酸 (Tet) 衍生物,以克服毒性和生物可用性问题. 结构修改增强了抗瘤和抗菌活性,为改进的治疗剂铺平了道路.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 泰特兰丁 (Tet) 是一种双基素类化合物,表现出多种药理学效应.
- 泰特的临床应用受到毒性,溶解性差,生物可用性低的限制.
- 结构修改TET是提高其治疗潜力的关键策略.
研究的目的:
- 系统地审查Tet衍生品的结构修改策略.
- 为了评估Tet衍生物的生物活性.
- 为了指导进一步的优化和发现具有提高效率的类型.
主要方法:
- 关于Tet结构修饰及其对生物活动的影响的文献综述.
- 在特定位置 (C-5,C-14,C-12-甲基基基因) 的修改分析.
- 评估包括异环/基引入,功能组添加,盐形成和结构简化等策略.
主要成果:
- 在C-5 (异环/基) 和C-14 (胺基/胺基/电子提取组) 的修饰增强了抗瘤活性.
- 四级化改善了溶解性和抗菌活性.
- 对C-12-甲基基基基因的修改增强了代谢稳定性.
- 结构简化可能会产生新的抗癌化合物.
结论:
- 战略性结构修改可以显著改善Tet的药理学特征.
- 衍生物在增强抗瘤和抗菌应用方面表现有前途.
- 为了开发有效的治疗剂,需要对Tet结构优化的进一步研究.
相关概念视频
Structure-Activity Relationships and Drug Design
595
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
595
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146


